Warning: The NCBI web site requires JavaScript to function. more...
Fetching bibliography...
Generate a file for use with external citation management software.
Why Bile Acids Are So Important in Non-Alcoholic Fatty Liver Disease (NAFLD) Progression.
Gottlieb A, Canbay A.
Cells. 2019 Oct 30;8(11). pii: E1358. doi: 10.3390/cells8111358. Review.
Similar articles
Implications of Immunotherapy in Hepatobiliary Tumors.
Gottlieb A, Best J, Canbay A.
Visc Med. 2019 Mar;35(1):18-26. doi: 10.1159/000496755. Epub 2019 Feb 8. Review.
Single-Center Retrospective Study of Clinical and Laboratory Features That Predict Survival of Patients With Budd-Chiari Syndrome After Liver Transplant.
Jeschke B, Gottlieb A, Sowa JP, Jeschke S, Treckmann JW, Gerken G, Canbay A.
Exp Clin Transplant. 2019 Oct;17(5):665-672. doi: 10.6002/ect.2018.0274. Epub 2019 May 2.
Nonalcoholic-Fatty-Liver-Disease and Nonalcoholic Steatohepatitis: Successful Development of Pharmacological Treatment Will Depend on Translational Research.
Gottlieb A, Mosthael W, Sowa JP, Canbay A.
Digestion. 2019;100(2):79-85. doi: 10.1159/000493259. Epub 2018 Dec 7. Review.
How to Define Acute Liver Failure Patients with Pre-Existing Liver Disease without Signs of Cirrhosis.
Gottlieb A, Kottmann M, Manka P, Bedreli S, Hadem J, Bechmann L, Sowa JP, Gerken G, Canbay A.
Dig Dis. 2019;37(2):147-154. doi: 10.1159/000492869. Epub 2018 Sep 18.
The Presence and Severity of Nonalcoholic Steatohepatitis Is Associated with Specific Changes in Circulating Bile Acids.
Gottlieb A, Bechmann L, Canbay A.
Ann Hepatol. 2018 May-June;17(3):340-341. doi: 10.5604/01.3001.0011.7378. Epub 2018 Apr 9.
RITA displays anti-tumor activity in medulloblastomas independent of TP53 status.
Gottlieb A, Althoff K, Grunewald L, Thor T, Odersky A, Schulte M, Deubzer HE, Heukamp L, Eggert A, Schramm A, Schulte JH, Künkele A.
Oncotarget. 2017 Apr 25;8(17):27882-27891. doi: 10.18632/oncotarget.15840.
Filters: Manage Filters